FR2357256A1 - Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation - Google Patents

Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation

Info

Publication number
FR2357256A1
FR2357256A1 FR7705578A FR7705578A FR2357256A1 FR 2357256 A1 FR2357256 A1 FR 2357256A1 FR 7705578 A FR7705578 A FR 7705578A FR 7705578 A FR7705578 A FR 7705578A FR 2357256 A1 FR2357256 A1 FR 2357256A1
Authority
FR
France
Prior art keywords
pseudopest
preparation procedure
vaccines against
live vaccines
against avian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7705578A
Other languages
English (en)
Other versions
FR2357256B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recherche et Industrie Therapeutiques
Original Assignee
Recherche et Industrie Therapeutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recherche et Industrie Therapeutiques filed Critical Recherche et Industrie Therapeutiques
Publication of FR2357256A1 publication Critical patent/FR2357256A1/fr
Application granted granted Critical
Publication of FR2357256B1 publication Critical patent/FR2357256B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention est relative à des vaccins vétérinaires et à leur préparation. Les vaccins suivant l'invention contiennent une souche << froide >> ou << froide >> et thermosensible du virus de la pseudopeste aviaire obtenue par mutagénèse aux rayons ultraviolets ou à l'acide nitreux Les vaccins de l'invention sont utilisables dans la prévention de la pseudopeste aviaire, par administration aux poussins sous la forme d'un aérosoL
FR7705578A 1976-03-01 1977-02-25 Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation Granted FR2357256A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,770 US4053583A (en) 1976-03-01 1976-03-01 Live newcastle disease virus vaccines

Publications (2)

Publication Number Publication Date
FR2357256A1 true FR2357256A1 (fr) 1978-02-03
FR2357256B1 FR2357256B1 (fr) 1980-04-04

Family

ID=24659151

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7705578A Granted FR2357256A1 (fr) 1976-03-01 1977-02-25 Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation

Country Status (8)

Country Link
US (1) US4053583A (fr)
JP (1) JPS52105209A (fr)
BE (1) BE851880A (fr)
DE (1) DE2708668A1 (fr)
FR (1) FR2357256A1 (fr)
GB (1) GB1510100A (fr)
IL (1) IL51460A0 (fr)
PT (1) PT66193A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
US4618493A (en) * 1982-10-13 1986-10-21 Smithkline-Rit Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4554158A (en) * 1983-04-07 1985-11-19 Simonsen Laboratories, Inc. Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
DE3601922A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Stabilisiertes virus-antigen, verfahren zu seiner herstellung und seine verwendung
NZ224567A (en) * 1987-05-19 1990-08-28 Yissum Res Dev Co Vaccine against newcastle disease virus comprising a live immunogenic lentogenic or mesogenic strain of newcastle disease virus in combination with a liquid containing a mineral or vegetable oil
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
US6022726A (en) * 1992-02-03 2000-02-08 Palese; Peter Genetically engineered attenuated viruses
US6316243B1 (en) 1992-04-14 2001-11-13 Peter Palese Genetically engineered attenuated double-stranded RNA viruses
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
CA2181862C (fr) * 1995-08-01 2009-12-22 Carla Christina Schrier Vaccin antiviral attenue pour la maladie de newcastle
US6506385B1 (en) 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
WO2012151391A2 (fr) 2011-05-04 2012-11-08 Streck, Inc. Compositions virales inactivées et leurs procédés de préparation
CN103386125A (zh) * 2012-05-08 2013-11-13 刘江秋 肾综合征出血热鼻黏膜免疫气溶胶疫苗的研制

Also Published As

Publication number Publication date
US4053583A (en) 1977-10-11
BE851880A (fr) 1977-08-29
IL51460A0 (en) 1977-04-29
FR2357256B1 (fr) 1980-04-04
GB1510100A (en) 1978-05-10
PT66193A (en) 1977-03-01
DE2708668A1 (de) 1977-09-08
JPS52105209A (en) 1977-09-03

Similar Documents

Publication Publication Date Title
FR2357256A1 (fr) Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation
DE3263573D1 (en) Pharmaceutically active phenylcarboxylic acid derivatives
SE8300623D0 (sv) Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)
RU92004423A (ru) Препарат из растений curcuma
Rubin et al. Evidence for percutaneous inoculation as the mode of transmission for chromoblastomycosis
ES439966A1 (es) Preparado para el tratamiento de enfermedades infecciosas, procedimiento para su obtencion y su empleo.
EP0046909A3 (en) Pharmaceutical composition
FR2388564A1 (fr) Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
FR2388050A1 (fr) Procede pour la preparation d&#39;une couche virale de gastro-enterite transmissible attenuee a appliquer aux vaccins vivants
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
ATE96662T1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
DE1950774A1 (de) Heteroploide Zellinien
KR900001697A (ko) 치료용 화합물
KR910005886A (ko) 안정화 백혈구 인터페론
CARLSTRÖM Appearance in Children's Sera of Substances Capable of Neutralizing Canine Distemper Virus 1: Preliminary Report
DE3872881D1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
Jo Therapeutic experiments on red spot disease
Cummings et al. Animal model for human disease: Idiopathic polyneuritis, Guillain-Barré Syndrome. Animal model: Coonhound paralysis, idiopathic polyradiculoneuritis of coonhounds.
DE68907280T2 (de) Avirulenter Tollwut-Impfstoff.
DE3279264D1 (en) Method of immunizing pigs against aujeszky&#39;s disease
DE2437166C3 (de) Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten
SU1069818A1 (ru) Способ профилактики гриппа
DK263579A (da) Fremgangsmaade til fremstilling af n1-benzoyln2-phenyl-1,3-diaminopropan-2-ol-forbindelser eller metaloxidforbindelser af hydroxyderivaterne i benzoylgruppen deraf eller syreadditionssalte deraf
KAMEL et al. Effect of harmine and harmaline hydrochloride on pregnancy in white rats

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse